Before a medical device can be legally marketed in the KSA, manufacturers must obtain a Medical Device Marketing Authorization (MDMA) — the official approval confirming that a device meets SFDA's regulatory, safety, and performance requirements based on a full technical file review. Devices are classified into four risk-based classes, Class A, B, C, and D, based on 22 classification rules for medical devices and seven rules for IVDs. All submissions are made electronically through SFDA's Unified Electronic System (GHAD).
Saudi Arabia Pathway at a Glance
| Step | What happens | Indicative time |
|---|---|---|
| 1. Appoint Authorized Representative | Licensed AR registered in the Medical Devices National Registry (MDNR) | 1–4 weeks |
| 2. Classify device | SFDA Class A–D using the MDS-G008 rules | 1 week |
| 3. Prepare technical file | Technical File Assessment (TFA) dossier, labeling (Arabic for lay users), UDI data | 4–8 weeks |
| 4. Submit via GHAD | Application and fee payment | 1–2 weeks |
| 5. SFDA review | Official review: 35 working days, excluding time taken to answer queries | 2–5 months in practice |
| 6. MDMA issued | Valid up to 3 years; renew before expiry | — |
Need for Local Authorized Representative
Foreign manufacturers without a legal entity in Saudi Arabia are required to appoint a Local Authorized Representative (LAR) to act on their behalf. The Authorized Representative must obtain an Authorized Representative License, renewable annually, to legally represent the manufacturer in the KSA, and is responsible for submitting all application documents to the SFDA for device registration.
The LAR's role extends well beyond filing your application. Their name, address, and contact information appear on the device's technical documentation, labeling, packaging, and instructions for use, and they are responsible for maintaining post-market compliance and vigilance including reporting device modifications and adverse events to the SFDA, as well as submitting renewal applications to keep the registration active. Each LAR must be duly licensed with the SFDA and register through the Medical Devices National Registry portal to obtain a national registry number.
Because the AR is your legal presence in the KSA, check three things before you sign:
- the AR's licence is current;
- it has handled devices like yours before;
- it has a clear way of passing SFDA's queries to you, and quickly.
If you change LARs later, a registration can be transferred to the new one through SFDA's systems. Plan the handover so market access never lapses.
Without a properly appointed and licensed LAR, a foreign manufacturer cannot register or market a device in KSA. We help can connect you with a trusted, experienced LAR, where needed, to manage this role reliably.
Device Classification: Class A to D
The SFDA classifies medical devices into four risk-based categories — Class A, B, C, and D — with Class A representing the lowest risk and Class D the highest. Classification is determined using 22 defined rules for medical devices and seven rules for IVDs, based on factors such as duration of body contact, invasiveness, and intended use.
Class decides the route:
- Class A (low risk): may qualify for the Medical Device Listing (MDL) route instead of full review.
- Class B, C and D: full Medical Device Marketing Authorization (MDMA).
- Class A with extra risk factors: devices supplied sterile, with a measuring function, or that are reusable surgical instruments follow the MDMA route too.
Before settling on a class, compare how your device is classified in your reference markets (US, EU, Canada, Australia, Japan). SFDA's rules don't map one for one onto theirs, so the same device can land in a different class. In case of any confusion, resolve that before you build the file.
Accurate classification at the outset ensures the right documentation is prepared from day one, avoiding delays later in the process.
Read more about SFDA Device Classification (MDS-G008) →
Guidance on Medical Devices Classification (MDS – G008) (SFDA) →
MDMA Registration (Technical File Assessment)
Under MDS-REQ 1, a device can be made available in the Kingdom of Saudi Arabia only if it is registered and holds an MDMA. Medical Device Marketing Authorization (MDMA) is the official SFDA approval required based on a comprehensive review of the technical file. Since January 2022 the applicable route has been MDMA-2 where SFDA carries out its own Technical File Assessment (TFA) and conformity evaluation, whatever approvals you already hold abroad.
Regulation Update: MDMA-1 — Previously allowed devices already approved in GHTF reference markets (EU, US, Canada, Australia, Japan) to leverage those approvals for Saudi registration. This pathway was discontinued at the end of 2021. If the licence was issued under GHTF, this will have to be renewed under TFA.
So, does your CE or FDA paperwork still help? Yes, a lot. Most of what SFDA asks for already sits in a well-built CE or FDA file: the device description, risk management, verification and validation, clinical evidence and labeling. The work is reorganizing it to SFDA's structure and closing the gaps.
In practice, this stage covers:
- compiling and organizing the technical file to SFDA's requirements;
- preparing the supporting documents;
- submitting through the GHAD electronic system and answering SFDA's queries.
Our goal is to help you build a submission that moves efficiently through SFDA review.
Read more about MDMA Registration and the Technical File Assessment →
Labelling & Documentation: Arabic and English Requirements
Language depends on who uses the device. Technical documentation is generally accepted in English. For professional-use devices, labeling and instructions for use (IFU) may also be in English. For devices used by lay users, including home-use devices, SFDA's essential principles call for information and any electronic user interface in both Arabic and English. Self-testing IVDs follow the same rule.
Two smaller points catch people out. Labels must not carry the SFDA logo, but they may show the Medical Device National Listing number. And the LAR's name and address must appear on the labeling, packaging and IFU.
We help with:
- reviewing your labeling and IFU against SFDA's language requirements;
- coordinating translation and localization where Arabic is needed;
- keeping the technical file, labeling and marketing materials consistent with one another;
- formatting documents to SFDA's submission standards.
Getting this right the first time saves a round of queries during review.
Post-Market Surveillance & Vigilance (NCMDR Reporting)
Once a device is on the market, manufacturers, Local Authorized Representative, importers, distributors, and healthcare providers share ongoing responsibility for monitoring device safety and performance. Adverse events and complaints are reported to the National Center for Medical Device Reporting (NCMDR). The manufacturer is also expected to conduct follow-up investigations and provide all relevant documentation and information SFDA asks for.
A few other duties are worth building into your procedures from day one:
- A post-market surveillance plan and report that MDS-REQ 1 lists among the documents for authorization.
- A distribution tracking system for manufacturers, LARs, importers and distributors to record who the device is supplied to.
- Change notifications to be sent to SFDA electronically about any significant changes, within the 10-day window set by MDS-REQ 1.
- Response time for documentation requested by SFDA. Even after MDMA is granted, SFDA can ask for your technical documentation at any time and expects it within 10 days. Procedure should be in place to address these requests.
We help set up surveillance and vigilance processes that match these requirements, support adverse event and complaint reporting, and coordinate the investigation and paperwork when an incident is reported. A process that is already running when something goes wrong makes a far better impression than one assembled in a hurry.
Keeping MDMA Valid: Renewal Support
An MDMA certificate is generally valid for three (3) years. MDS-REQ 1 requires it to be renewed before it expires, and a renewal request can be submitted up to 90 days before the expiry date. So, the practical window opens about three months before the deadline, and it's better to use it.
Renewal requires demonstrating ongoing compliance with SFDA requirements and may involve updates to technical documentation, labeling, or other supporting information reflecting any changes since initial authorization. If your licence was issued under the old GHTF route, the renewal will go through a full Technical File Assessment.
With renewal support built into our services, we help ensure your device registration remains continuously valid, to avoid any gaps in market authorization.
Why Work With Us
SFDA registration has several moving parts, and each one depends on the last. We handle them as one journey rather than a set of separate tasks.
- One team from classification to renewal: The same people who classify your device prepare the file and plan the renewal, so nothing gets lost in a handover.
- Built on SFDA's own documents: We work from the requirements themselves, such as MDS-REQ 1 and MDS-G008, not from second-hand summaries.
- Your existing work, put to use: We adapt your CE or FDA documentation to SFDA's format instead of starting again.
- Local representation arranged: Where you need a Local Authorized Representative, we connect you with an experienced, licensed one.